Association Between Sarcopenia, Clinical Outcomes, and Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunochemotherapy: A Prospective Cohort Study
Patients with Extensive SCLC and sarcopenia had worse clinical outcomes and shorter OS. Sarcopenia is a prognostic factor affecting first-line treatment efficacy and long-term survival of patients with SCLC in the era of immunotherapy.
Authors
- Shaoming Wang (ORCID: https://orcid.org/0000-0002-3980-1919)
- Jiaxin Huang (ORCID: https://orcid.org/0000-0002-7430-7967)
- Le Tian (ORCID: https://orcid.org/0000-0001-6244-3956)
- Na Li (ORCID: https://orcid.org/0000-0002-0392-6672)
- Ning Li (ORCID: https://orcid.org/0000-0002-6518-2541)
- Zhijie Wang (ORCID: https://orcid.org/0000-0002-7722-4956)
- Xi Zhang (ORCID: https://orcid.org/0000-0002-3869-3856)
- Jie Zhang (ORCID: https://orcid.org/0000-0001-6717-4118)
- Lei Yu (ORCID: https://orcid.org/0000-0002-8837-2022)
- Minghua Cong (ORCID: https://orcid.org/0000-0002-1082-9598)
- Rui Wan (ORCID: https://orcid.org/0000-0003-1958-1784)
- Chen-Xin Song (ORCID: https://orcid.org/0009-0009-7306-5140)
- Xinqi Liu
- Xinyi Wang (ORCID: https://orcid.org/0009-0003-5429-9853)
Institutions
- Hebei Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Nutrition and Cancer
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1080/01635581.2024.2392297
- Citations
- 4
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.31